non-nucleoside

Interviews and expert commentary tagged “non-nucleoside” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
Audio Journal of Oncology

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates

Pedro Cahn REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires Etraviri

21 September 2007
0:00
Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone
Audio Journal of Oncology

Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone

ROY STEIGBIGEL, State University of New York at Stony Brook JOHN W. MELLORS, University of Pittsburgh REFERENCE: Abstract 105aLB, 105bLB, 14th Conference on Retroviruses and Opportunistic Infections,

6 March 2007
0:00
← Browse all episodes